ABUS
Arbutus Biopharma Corp
NASDAQ: ABUS · HEALTHCARE · BIOTECHNOLOGY
$4.13
-0.48% today
Updated 2026-04-29
Market cap
$813.36M
P/E ratio
—
P/S ratio
57.75x
EPS (TTM)
$-0.17
Dividend yield
—
52W range
$3 – $5
Volume
2.5M
Arbutus Biopharma Corp (ABUS) Insider transactions
Net insider activity
Net buying (36,567,487 shares)
Buy transactions
84
Sell transactions
16
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-02 | NGUYEN, TUAN | Chief Financial Officer | Buy | 188,400 | — | — |
| 2026-02-02 | NGUYEN, TUAN | Chief Financial Officer | Buy | 73,500 | — | — |
| 2026-02-02 | ANDROSKI, LINDSAY | Director, President and CEO | Buy | 71,700 | — | — |
| 2026-02-02 | ANDROSKI, LINDSAY | Director, President and CEO | Buy | 28,000 | — | — |
| 2025-08-04 | SAWHNEY, ROGER | Director | Buy | 157,600 | — | — |
| 2025-03-31 | NGUYEN, TUAN | Chief Financial Officer | Buy | 750,000 | — | — |
| 2025-03-18 | HASIJA, ANUJ | Director | Buy | 157,600 | — | — |
| 2025-03-18 | BEARDSLEY, ROBERT A | Director | Buy | 157,600 | — | — |
| 2025-03-18 | ANDROSKI, LINDSAY | Director, President and CEO | Buy | 310,422 | — | — |
| 2025-02-14 | SIMS, KAREN | Chief Medical Officer | Buy | 200,300 | — | — |
| 2025-02-14 | SIMS, KAREN | Chief Medical Officer | Buy | 49,300 | — | — |
| 2025-02-14 | NAFTZGER, J. CHRISTOPHER | General Counsel and CCO | Buy | 220,300 | — | — |
| 2025-02-14 | NAFTZGER, J. CHRISTOPHER | General Counsel and CCO | Buy | 54,300 | — | — |
| 2025-02-14 | MCELHAUGH, MICHAEL J. | Director, Interim President & CEO | Buy | 718,800 | — | — |
| 2025-02-14 | MCELHAUGH, MICHAEL J. | Director, Interim President & CEO | Buy | 177,000 | — | — |
| 2025-02-14 | HASTINGS, DAVID C | Chief Financial Officer | Buy | 365,800 | — | — |
| 2025-02-14 | HASTINGS, DAVID C | Chief Financial Officer | Buy | 90,100 | — | — |
| 2025-02-04 | SIMS, KAREN | Chief Medical Officer | Sale | 19,348 | $3.28 | $63519.48 |
| 2025-02-04 | NAFTZGER, J. CHRISTOPHER | General Counsel and CCO | Sale | 11,333 | $3.28 | $37206.24 |
| 2025-02-04 | MCELHAUGH, MICHAEL J. | Director, Interim President & CEO | Sale | 23,790 | $3.28 | $78102.57 |
| 2025-02-04 | HASTINGS, DAVID C | Chief Financial Officer | Sale | 22,183 | $3.28 | $72826.79 |
| 2024-08-14 | MANCHESTER, KEITH S | Director | Sale | 54,915 | — | — |
| 2024-08-14 | MANCHESTER, KEITH S | Director | Buy | 54,915 | $0.56 | $30752.40 |
| 2024-08-14 | MANCHESTER, KEITH S | Director | Sale | 8,846 | $3.69 | $32637.32 |
| 2024-05-23 | TORTI, FRANK | Director | Buy | 67,000 | — | — |
| 2024-05-23 | REWOLINSKI, MELISSA | Director | Buy | 67,000 | — | — |
| 2024-05-23 | MEYERS, JAMES R | Director | Buy | 67,000 | — | — |
| 2024-05-23 | MANCHESTER, KEITH S | Director | Buy | 67,000 | — | — |
| 2024-05-23 | HENRIQUES, RICHARD C JR | Director | Buy | 67,000 | — | — |
| 2024-05-23 | BURGESS, DANIEL D | Director | Buy | 67,000 | — | — |
| 2024-02-02 | SOFIA, MICHAEL J. | Chief Scientific Officer | Sale | 9,982 | $2.31 | $23083.38 |
| 2024-02-02 | SIMS, KAREN | Chief Medical Officer | Sale | 4,358 | $2.31 | $10077.88 |
| 2024-02-02 | MCELHAUGH, MICHAEL J. | Director, Interim President & CEO | Sale | 10,164 | $2.31 | $23504.25 |
| 2024-02-02 | HASTINGS, DAVID C | Chief Financial Officer | Sale | 9,593 | $2.31 | $22183.81 |
| 2024-02-01 | SOFIA, MICHAEL J. | Chief Scientific Officer | Buy | 437,800 | — | — |
| 2024-02-01 | SOFIA, MICHAEL J. | Chief Scientific Officer | Buy | 109,500 | — | — |
| 2024-02-01 | SIMS, KAREN | Chief Medical Officer | Buy | 403,900 | — | — |
| 2024-02-01 | SIMS, KAREN | Chief Medical Officer | Buy | 101,000 | — | — |
| 2024-02-01 | NAFTZGER, J. CHRISTOPHER | General Counsel and CCO | Buy | 380,500 | — | — |
| 2024-02-01 | NAFTZGER, J. CHRISTOPHER | General Counsel and CCO | Buy | 95,100 | — | — |
| 2024-02-01 | MCELHAUGH, MICHAEL J. | Director, Interim President & CEO | Buy | 495,100 | — | — |
| 2024-02-01 | MCELHAUGH, MICHAEL J. | Director, Interim President & CEO | Buy | 123,800 | — | — |
| 2024-02-01 | HASTINGS, DAVID C | Chief Financial Officer | Buy | 450,000 | — | — |
| 2024-02-01 | HASTINGS, DAVID C | Chief Financial Officer | Buy | 112,500 | — | — |
| 2023-07-12 | REWOLINSKI, MELISSA | Director | Buy | 110,000 | — | — |
| 2023-07-10 | SIMS, KAREN | Chief Medical Officer | Buy | 153,640 | — | — |
| 2023-07-10 | NAFTZGER, J. CHRISTOPHER | General Counsel and CCO | Buy | 500,000 | — | — |
| 2023-05-24 | TORTI, FRANK | Director | Buy | 55,000 | — | — |
| 2023-05-24 | MEYERS, JAMES R | Director | Buy | 55,000 | — | — |
| 2023-05-24 | MANCHESTER, KEITH S | Director | Buy | 55,000 | — | — |
| 2023-05-24 | HENRIQUES, RICHARD C JR | Director | Buy | 55,000 | — | — |
| 2023-05-24 | BURGESS, DANIEL D | Director | Buy | 55,000 | — | — |
| 2023-02-01 | SOFIA, MICHAEL J. | Chief Scientific Officer | Buy | 328,700 | — | — |
| 2023-02-01 | SOFIA, MICHAEL J. | Chief Scientific Officer | Buy | 82,200 | — | — |
| 2023-02-01 | MCELHAUGH, MICHAEL J. | Chief Business Officer | Buy | 334,700 | — | — |
| 2023-02-01 | MCELHAUGH, MICHAEL J. | Chief Business Officer | Buy | 83,700 | — | — |
| 2023-02-01 | HOWARD, ELIZABETH | EVP, GC, Compliance | Buy | 278,700 | — | — |
| 2023-02-01 | HOWARD, ELIZABETH | EVP, GC, Compliance | Buy | 69,700 | — | — |
| 2023-02-01 | HASTINGS, DAVID C | Chief Financial Officer | Buy | 316,000 | — | — |
| 2023-02-01 | HASTINGS, DAVID C | Chief Financial Officer | Buy | 79,000 | — | — |
| 2023-02-01 | COLLIER, WILLIAM H. | Director, President and CEO | Buy | 866,000 | — | — |
| 2023-02-01 | COLLIER, WILLIAM H. | Director, President and CEO | Buy | 216,500 | — | — |
| 2022-05-25 | TRAN, TRAM | Director | Buy | 41,000 | — | — |
| 2022-05-25 | TORTI, FRANK | Director | Buy | 41,000 | — | — |
| 2022-05-25 | MEYERS, JAMES R | Director | Buy | 41,000 | — | — |
| 2022-05-25 | MANCHESTER, KEITH S | Director | Buy | 41,000 | — | — |
| 2022-05-25 | HENRIQUES, RICHARD C JR | Director | Buy | 41,000 | — | — |
| 2022-05-25 | BURGESS, DANIEL D | Director | Buy | 41,000 | — | — |
| 2022-01-20 | SOFIA, MICHAEL J. | Chief Scientific Officer | Buy | 285,000 | $2.81 | $800850.00 |
| 2022-01-20 | PICCHIO, GASTON | Chief Development Officer | Buy | 256,500 | $2.81 | $720765.00 |
| 2022-01-20 | MCELHAUGH, MICHAEL J. | Chief Business Officer | Buy | 325,850 | $2.81 | $915638.50 |
| 2022-01-20 | HOWARD, ELIZABETH | Chief Compliance Officer | Buy | 237,500 | $2.81 | $667375.00 |
| 2022-01-20 | HASTINGS, DAVID C | Chief Financial Officer | Buy | 285,000 | $2.81 | $800850.00 |
| 2022-01-20 | COLLIER, WILLIAM H. | Director, President and CEO | Buy | 787,550 | $2.81 | $2.21M |
| 2021-12-01 | SOFIA, MICHAEL J. | Chief Scientific Officer | Sale | 200,000 | $5.09 | $1.02M |
| 2021-11-09 | TRAN, TRAM | Director | Buy | 44,000 | — | — |
| 2021-10-18 | ROIVANT, SCIENCES LTD. | 10% Owner | Sale | 1,164,000 | — | — |
| 2021-10-18 | ROIVANT, SCIENCES LTD. | 10% Owner | Buy | 22,833,922 | — | — |
| 2021-06-03 | TORTI, FRANK | Director | Buy | 22,000 | — | — |
| 2021-06-03 | MEYERS, JAMES R | Director | Buy | 22,000 | — | — |
| 2021-06-03 | MANCHESTER, KEITH S | Director | Buy | 22,000 | — | — |
| 2021-06-03 | HENRIQUES, RICHARD C JR | Director | Buy | 22,000 | — | — |
| 2021-06-03 | CHENG, ANDREW | Director | Buy | 22,000 | — | — |
| 2021-06-03 | BURGESS, DANIEL D | Director | Buy | 22,000 | — | — |
| 2021-02-13 | SOFIA, MICHAEL J. | Chief Scientific Officer | Buy | 290,000 | — | — |
| 2021-02-13 | PICCHIO, GASTON | Chief Development Officer | Buy | 250,000 | — | — |
| 2021-02-13 | MCELHAUGH, MICHAEL J. | Chief Business Officer | Buy | 249,000 | — | — |
| 2021-02-13 | HOWARD, ELIZABETH | Chief Compliance Officer | Buy | 200,000 | — | — |
| 2021-02-13 | HASTINGS, DAVID C | Chief Financial Officer | Buy | 250,000 | — | — |
| 2021-02-13 | COLLIER, WILLIAM H. | Director, President and CEO | Buy | 675,000 | — | — |
| 2021-02-09 | MCELHAUGH, MICHAEL J. | Chief Business Officer | Sale | 20,000 | $5.00 | $100000.00 |
| 2020-12-14 | MCELHAUGH, MICHAEL J. | Chief Business Officer | Sale | 30,000 | $5.00 | $150000.00 |
| 2020-12-14 | MCELHAUGH, MICHAEL J. | Chief Business Officer | Sale | 10,000 | $5.00 | $50032.00 |
| 2020-09-23 | PICCHIO, GASTON | Chief Development Officer | Buy | 50,000 | — | — |
| 2020-09-23 | COLLIER, WILLIAM H. | Director, President and CEO | Buy | 70,000 | — | — |
| 2020-07-23 | MCELHAUGH, MICHAEL J. | Chief Business Officer | Sale | 20,000 | $5.01 | $100200.00 |
| 2020-05-28 | TORTI, FRANK | Director | Buy | 22,000 | — | — |
| 2020-05-28 | MEYERS, JAMES R | Director | Buy | 22,000 | — | — |
| 2020-05-28 | MANCHESTER, KEITH S | Director | Buy | 22,000 | — | — |
| 2020-05-28 | HENRIQUES, RICHARD C JR | Director | Buy | 22,000 | — | — |